Meet the Cancer Equity Leaders! NCI Disparities announced the formation of this diverse team of renowned cancer leaders—including AACI President Dr. Rob Winn and other members of AACI’s Board of Directors—earlier this week. Learn more: cancer.gov/about-nci/orga… #CancerHealthEquity

UH biomedical research grants pump millions into state economy hawaii.edu/news/2024/04/1…

In Hawai‘i, our intense sunlight has a higher UV index and, unfortunately, an increased risk for #skin #cancer . The University of Hawaii Cancer Center is driving awareness with our mobile van, educating our community about skin cancer prevention. Stay sun-safe!

hawaii.edu/news/2024/04/0…

I enjoyed AACR 2024 meetings. It was packed with committee and meetings with pharma, diagnostic companies, mentees, colleagues, collaborators, etc. Non-stop. I did not even have time to take pictures. :( I need to control my time more next year. #AACR24

Nice view of Los Angeles and the San Diego area from@united flight.

I enjoyed AACR 2024 meetings. It was packed with committee and meetings with pharma, diagnostic companies, mentees, colleagues, collaborators, etc. Non-stop. I did not even have time to take pictures. :( I need to control my time more next year. #AACR24

.U.S. FDA approved T-DXd (Enhertu) for patients with HER2 3+ solid tumors who received prior systemic therapy & no satisfactory alternative treatment, based on DESTINY-PanTumor02, DESTINY-Lung01, and DESTINY-CRC02. This is an exciting time.

m.email.asco.org/nl/jsp/m.jsp?c…

Dr. Song-Yi Park, PhD, has been awarded a $140,000 grant from the Alzheimer’s Association to test the recently recommended blood test for Alzheimer’s disease diagnosis in the Multiethnic Cohort Study

Follow the link to read the story ow.ly/ziCm50R4Cux

#Alzheimers #MEC

If studies consistently demonstrate the efficacy of T-DXd across all categories, we may be heading towards a practice where selecting patients for T-DXd based on HER2 expression levels might become unnecessary. Consequently, HER2 could become a predictive biomarker with limited…

.University of Hawaii Cancer Center has a gorgeous lanai to relax for lunch and have a scientific discussion. Or simply to chill out. You can see the Pacific Ocean, and during the winter season, we can see the whales.

In the city of lights, we’re illuminating breakthrough innovations and research that are improving global cancer care today—and you need to be there to see it. Join us at ASCO Breakthrough in Yokohama, Japan.

Withdrawn | Cancer Accelerated Approvals. There are 28 drugs. That is why we need to be careful of how we interpret data from drugs based on accelerated approval. fda.gov/drugs/resource…

The OXEL trial, led by Filipa Lynce, MD, FASCO, is out on Nature Communications. Among 45 pts with residual TNBC after NAT, adjuvant nivo/cape were well tolerated, increased peripheral immune score & led to numerically improved 2y iDFS (91%) vs nivo (47%) or cape alone (53%). nature.com/articles/s4146…

Establishing conditions for the generation and maintenance of #estrogen receptor-positive #organoid models of #breastcancer : …ast-cancer-research.biomedcentral.com/articles/10.11…

Good Morning New York from Newark Liberty International Airport, United Airlines terminal, United flight early flight leaving!

Beautiful campus of University of Hawaii at Manoa!

The whale migration is almost over. And I was lucky enough to see the whales from our University of Hawaii Cancer Center. Brings me happiness.

The whale migration is almost over. And I was lucky enough to see the whales from our University of Hawaii Cancer Center. Brings me happiness.